Amgen and Novartis have cleared one of the final hurdles in the tight race to bring a CGRP migraine drug to market.

Acceleron has brought in a top commercial exec from Bayer, Habib Dable, to lead the company as it aims to plan for a marketed product.

Boehringer Ingelheim is making a bid in oncolytic viruses in a deal with preclinical ViraTherapeutics that’s worth up to €210 million. As part of the deal, the…

New research from the Human Microbiology Institute has shown that many diseases, from Alzheimer’s to cancer and others, could be linked to bacterial viruses, a…

Shares in tiny Galectin Therapeutics fell 50% in after-hours trading on the back of data from a Phase IIa nonalcoholic steatohepatitis trial.

GlaxoSmithKline has found a buyer for a French drug discovery site rendered redundant by its revamped dual-hub R&D model.

National Institutes of Health (NIH) researchers say DNA methylation is persistently altered in individuals with a smoking history, and the results may lead to…

Shire has returned rights to the two biosimilars that Baxalta had in development.